- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 19/00 - Hybrid peptides
Patent holdings for IPC class C07K 19/00
Total number of patents in this class: 11650
10-year publication summary
|
592
|
787
|
824
|
911
|
1007
|
966
|
910
|
882
|
804
|
614
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20960 |
204 |
| The Trustees of the University of Pennsylvania | 4444 |
115 |
| The Board of Trustees of the Leland Stanford Junior University | 6724 |
80 |
| Regeneron Pharmaceuticals, Inc. | 4873 |
78 |
| National Research Council of Canada | 1554 |
59 |
| Chugai Seiyaku Kabushiki Kaisha | 1435 |
58 |
| The General Hospital Corporation | 4900 |
54 |
| Osaka University | 3248 |
54 |
| The University of Tokyo | 4403 |
54 |
| F. Hoffmann-La Roche AG | 7795 |
52 |
| Acceleron Pharma Inc. | 339 |
51 |
| JCR Pharmaceuticals Co., Ltd. | 226 |
50 |
| President and Fellows of Harvard College | 6118 |
47 |
| Nanjing Legend Biotech Co., Ltd. | 190 |
47 |
| Board of Regents, The University of Texas System | 6187 |
45 |
| The Johns Hopkins University | 5957 |
45 |
| Memorial Sloan-Kettering Cancer Center | 2069 |
45 |
| Ajinomoto Co., Inc. | 2291 |
40 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3024 |
39 |
| Novartis AG | 10170 |
37 |
| Other owners | 10396 |